Avantax Advisory Services
ATYR icon

Avantax Advisory Services’s aTyr Pharma ATYR Stock Holding History

Avantax Advisory Services’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$292K Buy
+57,669
New +$227K ﹤0.01% 1925

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Avantax Advisory Services's ATYR Position: Q2 2025 in Review

Avantax Advisory Services opened a new position in aTyr Pharma (ATYR) in Q2 2025: 57,669 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #1925 among its holdings.

110 funds tracked by Wall St. Rank hold ATYR as of Q2 2025.

  • Avantax Advisory Services held 57,669 shares of aTyr Pharma worth $292K as of Q2 2025.
  • aTyr Pharma was a new Avantax Advisory Services position in Q2 2025.
  • aTyr Pharma made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1925 holding.
  • 110 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.